Here, we provide evidence that the IFNs’ effect on CLL cell survival is in part due to the activation of TYK2 (for type I IFN) or JAK2 (for type II IFN), leading to the sequential stimulation of STAT3 and Mcl-1. This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.